Gene: IGF2BP1
Official Full Name: insulin like growth factor 2 mRNA binding protein 1provided by HGNC
Gene Summary: This gene encodes a member of the insulin-like growth factor 2 mRNA-binding protein family. The protein encoded by this gene contains four K homology domains and two RNA recognition motifs. It functions by binding to the mRNAs of certain genes, including insulin-like growth factor 2, beta-actin and beta-transducin repeat-containing protein, and regulating their translation. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
GP00408 | IGF2BP1 gRNA3-gRNA4 KO plasmid | IGF2BP1 | $850 | |||
KO00732 | IGF2BP1 Knockout cell line(A-375) | Human | IGF2BP1 | 1:3~1:4 | Negative | Online Inquiry |
KO01458 | IGF2BP1 Knockout cell line(A549) | Human | IGF2BP1 | 1:3~1:4 | Negative | Online Inquiry |
KO16992 | IGF2BP1 Knockout cell line (HeLa) | Human | IGF2BP1 | 1:3~1:6 | Negative | Online Inquiry |
KO16993 | IGF2BP1 Knockout cell line (HEK293) | Human | IGF2BP1 | 1:3~1:6 | Negative | Online Inquiry |
IGF2BP1 Gene Knockout Cell Lines are a cutting-edge tool designed for researchers investigating the role of insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in various biological processes. IGF2BP1 is a key regulator of mRNA stability and translation, influencing cellular growth, differentiation, and response to stress. By employing CRISPR-Cas9 gene editing technology, these knockout cell lines effectively eliminate the expression of IGF2BP1, providing a unique model to study its functional consequences within cellular systems.
The primary mechanism of the IGF2BP1 gene knockout is based on the introduction of double-strand breaks in the genomic DNA, leading to insertions or deletions (indels) that disrupt the open reading frame of the IGF2BP1 gene. This results in the silencing of IGF2BP1-mediated post-transcriptional regulation, allowing researchers to delineate the impacts on mRNA targets and downstream signaling pathways. Such investigations are vital for understanding the implications of IGF2BP1 in oncogenesis, stem cell biology, and developmental processes.
Scientifically, these knockout cell lines hold significant potential for applications in cancer research, where IGF2BP1 has been implicated in tumor progression and metastasis. By using these models, researchers can explore the therapeutic possibilities of targeting IGF2BP1 in various malignancies. Additionally, in drug discovery and toxicology studies, understanding IGF2BP1 functions can provide insights into drug resistance mechanisms and cellular adaptation strategies.
One of the key advantages of using IGF2BP1 Gene Knockout Cell Lines is their precise genetic modification, which enables reproducibility and accuracy in experimental outcomes. Unlike traditional knockdown methods, which can lead to partial inhibition and variability, these knockout lines offer complete loss of function, making them a more reliable option for experimental designs. Furthermore, these cell lines are available in various backgrounds, allowing researchers the flexibility to choose a model that best fits their study needs.
For researchers and clinicians looking to advance their understanding of post-transcriptional regulation in health and disease, IGF2BP1 Gene Knockout Cell Lines offer a valuable, cutting-edge resource. With our company’s commitment to excellence in producing high-quality biological products, we strive to support the scientific community in making significant advancements in their research endeavors. The reliability and specificity of our knockout cell lines ensure that your research can thrive with the best tools at your disposal.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.